Abstract. Infectious bursal disease virus (IBDV), family Birnaviradae, is the etiologic agent of a commercially important, globally distributed, contagious, immunosuppressive disease of young chickens. A restriction enzyme-compatible ssRNA internal control was developed for an IBDV reverse transcription/polymerase chain reaction-restriction fragment length polymorphism (RT/PCR-RFLP) diagnostic assay. An 841-bp bacteriophagelambda DNA fragment was directionally ligated to 3Ј and 5Ј oligonucleotide linkers containing the IBDV RT/ PCR target primer sequences. A pGEM-3Zf (ϩ) transcription vector containing the internal control construct was used in an in vitro transcription reaction to produce ssRNA. After RT and PCR amplification, the transcripts produced an 882-bp cDNA product, larger than, co-amplifiable with, and free of the restriction sites used to prepare RFLP patterns of the 743-bp IBDV cDNA target product. The limit of detection of the transcripts in the RT/PCR test is 3.2 femtograms. With the internal control, a test inhibition rate of 7.7% (20/261) was determined for the IBDV RT/PCR assay. By identifying inhibited tests, the assay was improved through a reduction in the number of false-negative results.
Infectious bursal disease virus (IBDV), a member of the Birnaviridae family, 3 is the causative agent of an economically important immunosuppressive disease of young chickens. The use of the reverse transcription/ polymerase chain reaction (RT/PCR) to detect IBDV in field and laboratory samples has been reported previously. 7, 11, 12, 17, 18, 21 A RT/PCR diagnostic assay for IBDV was developed in this laboratory. 8 In the assay, 743-bp RT/PCR products containing the coding sequence for a portion of the IBDV structural protein VP2 are digested with the restriction enzymes (REs) BstNI and MboI to yield a variety of restriction fragment length polymorphism (RFLP) patterns. These patterns are used to place field, vaccine, and previously characterized laboratory strains of the virus into different molecular groups. 7, 9 The application of PCR and RT/PCR methodologies in research and diagnostic testing has become commonplace since the first description of the PCR by Saiki. 16 Although these methods have led to the development of powerful diagnostic assays with respect to observed and theoretical sensitivity and specificity, they are also quite complex. A number of factors can influence the success or failure of an indi-vidual RT or PCR reaction. 10 A test reaction in which there is a failure of amplification due to impaired enzyme function, substrate availability, or reaction conditions can be defined as inhibited. From a diagnostic testing perspective, inhibited reactions are problematic because they are indistinguishable from negative test results. When failed test reactions are not identified, they result in a loss of test sensitivity because of the increased occurrence of false-negative results. To address this problem, individual researchers have developed a variety of PCR and RT/PCR internal control (IC) reagents to assist them in identifying inhibited reactions. 23 When added to individual test reactions, these reagents yield a readily distinguishable product, distinct from the target molecule product, that serves as a positive check on reaction performance. To diagnose IBDV, it is desirable to test a diverse variety of tissues that include fresh bursa, liver, proventriculus, chick embryo chorioallantoic membranes, and phenol-saturated bursa samples. 6 However, the performance of individual PCR and RT/ PCR tests can vary from 1 sample to another because of the presence of inhibitors. 4, 15, 19 The tissue type and the quality of extracted RNA have been noted to affect test performance. As an aide in monitoring reaction performance, and to identify the occurrence of false-negative tests due to reaction inhibition or technical errors in test preparation, a RE assay-compatible IC reagent was developed. The production and use of this IC is described. 
Materials and methods

Design of IC and preparation of ssRNA IC reagent
Identification of bacteriophage-genome fragment free of IBDV RE assay sites. The genome of bacteriophage-(LAMCG-Genbank Accession J02459) was analyzed for restriction sites with a commercial software package. a A circular map showing the restriction sites for BstnI, MboI, and SspI (used to analyze IBDV RT/PCR products) and KpnI, EcoRI, and BamHI (used in the internal control plasmid construction) was prepared to identify areas within the genome free of these restriction sites. The map was examined for restriction site-free segments between 750 and 1,000 bp in size so the IC cDNA product would be larger than the IBDV target. A StyI fragment 3.47 kbp (LAMCG-Genbank Accession J02459: nucleotides 24,397-27,868) was identified that when further restricted with MboI, yielded a fragment of 841 bp free of the RE sites listed above. The 841-bp segment identified had 5Ј MboI and 3Ј StyI overhanging ends, which allowed for the directional attachment of linkers containing the upstream and downstream target primers used in the IBDV RT/PCR-RFLP test. 8, 9 Isolation of bacteriophage-genome segment. Unmethylated bacteriophage-DNA b was restriction digested with StyI ( Fig. 1A) and separated by electrophoresis in a 1.0% low-melt agarose c gel prepared with 1 ϫ TAE buffer (0.089 M Tris base, 0.04 M acetate, 0.001 M ethylenediaminetetraacetic acid [EDTA] ) and visualized with ethidium bromide (EtBr) staining. The 3.47-kbp bacteriophage-StyI fragments were removed from the gel and recovered by a commercial silica bead purification system d in TE buffer (0.010 M Tris-HCl, 0.001 M EDTA, pH 8.0). The 3.47-kbp fragments were then digested with MboI e and separated in a 1.5% low-melt agarose gel prepared with 1 ϫ TAE buffer, and the 841-bp target fragments were recovered in TE buffer (pH 8.0) by a commercial silica bead DNA purification system d (Fig. 1B) .
Preparation of oligonucleotide linkers. Two linkers (Fig.  1C) containing the upstream or downstream IBDV RT/PCR primer sites and sequence complementary to the restriction site overhang regions of the 841-bp MboI-StyI lambda fragment and the KpnI restriction site of the pGEM-3Zf (ϩ) transcription vector b were prepared from 4 synthesized oligonucleotides. f The oligonucleotides were reconstituted in diethylpyrocarbonate-treated water (depcH 2 O) at a working concentration of 1.0 nmol/l. A phosphorylation reaction containing 27 U-T4 polynucleotide kinase, b 0.67 mM ATP, 1.0 nmol oligonucleotide, 70 mM Tris-HCl, (pH 7.6), 10 mM MgCl 2 , and 5 mM DTT was prepared for each oligonucleotide. The phosphorylation reactions were incubated at 37 C for 75 min. Linkers were prepared by combining the phosphorylation reaction mixtures of complementary oligonucleotide pairs, and allowing them to anneal by slow cooling in a water bath from 80 C to 40 C over a 3 hr period. After annealing, the linkers were examined by electrophoresis in an 8.0% polyacrylamide gel prepared with 0.5 ϫ TBE buffer (0.045 M Tris, 0.045 M borate, 0.001 M EDTA) and stained with EtBr to estimate their concentration and quality.
Preparation of 882-bp IC insert. The oligonucleotide linkers were ligated to the 241-bp bacteriophage-fragments to assemble the 882-bp IC inserts (Fig. 1C) . The ligation reaction containing 200 ng of -DNA (0.77 pmol) in TE buffer, pH 8.0, 5.5 pmol (0.8 l) of each linker, 10 ϫ ligation buffer (300 mM Tris-HCl, pH 7.8, 100 mM MgCl 2 , 100 mM DTT, 10 mM ATP), and 2.5 U T4 DNA ligase was incubated at 22 C for 3 hr. Ligase was then heat denatured at 70 C for 20 min to stop the reaction. The reaction products were digested for 2 hr at 37 C with KpnI (21.0 l ligation reaction, 3.5 l 10 ϫ buffer b [100 mM Tris-HCl, 70 mM MgCl 2 , 500 mM KCl, 10 mM DTT], 11.5 l depcH 2 O, and 40 U KpnI) to remove concatamers of the IC inserts. The resulting 882-bp IC inserts were isolated by electrophoresis in a 1% lowmelt agarose c gel and recovered by a commercial silica bead DNA purification procedure. d Cloning into pGEM3Zf(ϩ). Purified 882-bp IC constructs were ligated to pGEM-3Zf (ϩ) transcription vectors b ( Fig.  1D ) that had previously been linearized with KpnI and dephosphorylated with alkaline phosphatase g following the manufacturers' protocols. A ligation reaction containing 48 fmol 882-bp inserts, 10 fmol linearized vectors, 0.2 mM ATP, 10 ϫ ligation buffer (300 mM Tris-HCl, pH 7.8, 100 mM MgCl 2 , 100 mM DTT, 10 mM ATP), and 1.0 U T4 DNA ligase was prepared and incubated in a 16 C water bath overnight. The ligation reaction products were then used to transform DH5␣ cells. h Transformed colonies were selected by ␤-galactosidase/X-gal blue/white color screening and ampicillin (amp) selection.
In vitro transcription reaction. Four transformed colonies were subcultured on LB (Luria-Bertani) medium/amp/X-gal plates. Individual subcultured colonies were transferred to LB broth with 100 g/l ampicillin and grown overnight. Plasmid minipreps were prepared by an alkaline lysis method. 13 The presence of the infectious bursal disease (IBD) IC insert was verified by RE digestion and agarose gel electrophoresis of the recombinant plasmid (pGEM-IBD-IC) with BamHI and EcoRI. Plasmids containing the IC insert were linearized by restriction digestion with EcoRI and used as templates in a transcription reaction with a commercial in vitro transcription kit. i The SP6 promoter and polymerase were used to produce ssRNA runoff transcripts of the IC templates (Fig. 1E ). After transcription, the dsDNA templates were removed by digestion with RNase-free RQ1-DNase. b A modification of the manufacturer's protocol was necessary to obtain ssRNA transcripts free of dsDNA IBDV IC templates. After the first DNase digestion, the contents of the tube were transferred to a new siliconized Eppendorf tube. An additional 2.0 l of DNase was added to the reaction mix along with 60 l of 1 ϫ transcription buffer (40 mM Tris-HCl, pH 7.5, 6 mM MgCl 2 , 2 mM spermidine, 10 mM NaCl). This reaction was incubated at 37 C for 20 min. The reaction products were purified by phenol/chloroform/ isoamyl alcohol (25:24:1) extraction, 7.5 M ammonium acetate/ethanol precipitation, and washing with 70% ethanol. Unincorporated nucleotides were removed by 1 M ammonium acetate/ethanol precipitation, and the purified ssRNA was resuspended in a 20-l volume of TE buffer, pH 8.0.
Testing and characterization of the IBDV ssRNA IC
RT and PCR of ssRNA IC templates. Verification of the integrity of the ssRNA IC reagent and estimation of the appropriate working concentration were completed by using 10-fold serial dilutions (10 Ϫ2 -10
Ϫ9
) of the ssRNA IC templates in TE buffer, pH 8.0. Individual RT test reactions were prepared for the 10 Ϫ2 -10 Ϫ9 dilutions of the ssRNA transcripts by adding 16 l of an ice cold commercial RT/PCR kit j RT master mix solution (20 l reaction volume @ 5 mM MgCl 2 and 5 pmol each of the 5Ј and 3Ј IBDV primers) to 2.0 l of 90% dimethyl sulfoxide heated to 95 C for 3-5 min to duplicate, as closely as possible, the IBDV RT/PCR assay. g A 2.0-l aliquot of each ssRNA IC transcript dilution was then added to each of their individual reaction tubes. The RT reaction was incubated at 42 C for 1 hr. The PCR incubation temperatures and cycles were 95 C for 2 min (initial denaturation), then 95 C for 1 min, 53 C for 1.5 min, 72 C for 1 min for 35 cycles, with a final extension at 72 C for 7 min.
In addition, to assess the carryover of pGEM-IBD-IC dsDNA templates from the transcription reaction, 3 RT/PCR reactions were prepared without the reverse transcriptase enzyme (RT-negative proofing reactions). These reactions were prepared by adding a 2.0-l volume of the 10 Ϫ2 -10 Ϫ4 dilutions of ssRNA IC templates to RT reactions prepared as above except for the substitution of 1.0 l 1 ϫ PCR buffer (50 mM KCl, 10 mM Tris-HCl, pH 8.3) in exchange of the murine leukemia virus reverse transcriptase in the RT master mix preparation. After RT/PCR amplification, 10-l volumes of each reaction product were examined by agarose gel electrophoresis.
BstNI and MboI RE digestion of IBDV IC RT/PCR products. Ten-microliter aliquots of RT/PCR reaction products were digested with the REs BstNI e and MboI e at standard conditions and optimal buffers for each enzyme to demonstrate the absence of these restriction sites in the IC reagent. The 20-l reactions were incubated for 1 hr at the recommended temperatures for each enzyme. After digestion, the restriction products were examined by electrophoresis in a 1.0% agarose k gel prepared with 1 ϫ TBE buffer.
Utilization of the IC reagent in the IBDV RT/PCR assay. Review of 302 individual tests.
Ϫ6 dilution) of the ssRNA IC reagent, per test, added to the RT master mix preparation. After agarose k gel electrophoresis (1 ϫ TBE), the RT/PCR products of 302 reactions (268 run with and 34 run without the IC) were photographed l and the images reviewed to assess the performance of the reagent in the assay.
Results
Preparation of IBD IC, quantification, and restriction digest analysis. Initially, 10.5 g of -DNA was digested with StyI to obtain the 3.47-kbp StyI target fragment. After digestion with MboI and purification, approximately 100 ng of the 841-bp MboI-StyI fragment was obtained. After ligation of the linkers to the 841-bp fragment and digestion with KpnI to remove concatamers, the final yield of gel-purified inserts was approximately 20 ng (estimate from EtBr-stained gel). Six recombinant colonies were obtained after transformation of the DH5-␣ cells. h Plasmid minipreps prepared from subcultures of 4 of the transformed colonies were restriction digested with EcoRI and BamHI. After electrophoresis in a 1% agarose k gel prepared with 1 ϫ TBE, each plasmid isolate was found to contain a digestion fragment similar in size to purified 882-bp IC inserts.
The transcription reaction used to produce the IC transcripts was prepared by doubling the reagent volumes recommended for the positive control reaction of a commercial in vitro transcription kit. i A concentration of 180 ng/l ssRNA template in the purified ssRNA IC stock reagent was detected with the A260 absorbency value (0.018A). Converted, this translates to 3.07 ϫ 10 11 templates/l in the stock reagent. At the working dilution (0.5 l of 10 Ϫ6 dilution/test) of the stock reagent used in the RT/PCR assay, the single transcription reaction described produced IC reagent sufficient to run millions of tests. Stored preparations (50-l aliquots in siliconized Eppendorf tubes) of the IC have undergone no significant change in amplification quality after storage at Ϫ20 C for periods in excess of 18 months.
After the digestion of several samples of IC RT/ PCR cDNA product with BstNI or MboI, no digestion of the internal standard was observed. Additional digests run on samples containing IC and IBDV RT/PCR product showed no changes in the RFLP patterns obtained for the IBDV samples in the absence of the IC.
RT/PCR reactions of 10ϫ serial ssRNA IC reagent dilutions. RT negative proofing reactions. After RT/ PCR amplification and electrophoresis of the 10
Ϫ2 -10 Ϫ9 ssRNA IC reagent dilutions, gel bands were observed for the 10 Ϫ2 -10 Ϫ8 dilutions (Fig. 2) . In the 10 Ϫ8 reaction, the 882-bp IC product was seen as a faint band. No product was observed for the 10 Ϫ9 dilution reaction. With the value of 3.07 ϫ 10 11 templates/l in the stock reagent, at the 10 Ϫ8 dilution, the detection limit was 6,140 templates or 3.2 femtograms ssRNA template.
In the RT-negative PCR proofing reactions, evaluating the 10 Ϫ2 -10 Ϫ4 IC reagent dilutions for the presence of DNA templates carried over from the transcription reaction, a faint product band was detected Internal control reagent for IBDV RT-PCR in the 10 Ϫ2 dilution reaction. No product was observed at higher dilutions of the IC reagent. A working volume of 0.5 l of the 10 Ϫ6 dilution of the IC reagent is used in each RT/PCR IBDV test. Additional RT-negative PCR proofing reactions, at the working concentration, showed no production of cDNA product.
Review of 302 IBDV RT/PCR tests. A total of 302 IBDV RT/PCR tests were completed on 212 samples submitted for diagnostic testing. Test reactions were run at PCR MgCl 2 concentrations of 2, 3, or 4 mM. Each of the 212 test samples was run at least once with the IC and some at multiple MgCl 2 concentrations. Of the 302 tests conducted, 268 were run with the IC, whereas 34 tests were run with the 743-bp IBDV primer set alone.
A reaction run with the IC in which neither a 743-bp IBDV nor an 882-bp IC cDNA product was observed was defined as inhibited (Fig. 3) . Of the 268 controlled reactions conducted, 27 were determined to be inhibited. Because there was a bias for repeating tests on samples causing inhibition, 7 test results, each being a second (repeat) inhibited result for an individual RNA sample, were removed in determining an overall test inhibition rate of 7.7% (20/261 tests) for the assay.
For 34 test pairs, an individual RNA test sample was run both with and without the IC at the same PCR MgCl 2 concentration. When the results of the test pairs were compared, 21 sets were equivalent (i.e., agreement on ϩ or Ϫ status for IBDV). Ten test-pair reactions run with the IC were identified as inhibited and, correspondingly, as negative in reactions run without the IC (potential false negatives). Two test pairs were positive for IBDV in the reaction run with the IC and negative without the IC. One sample pair was negative in the test conducted with the IC and positive in the test run without the IC. Of the 3 (above) paired-test results in disagreement, 2 of the positive tests had only a trace or small amount of RT/PCR product, which we generally attribute to insufficient target material or consider a partially inhibited reaction.
The PCR MgCl 2 concentration at which a sample is tested can influence the success or failure of amplification in the IBDV RT/PCR assay, an effect common to most PCR reactions. When the results of the 302 tests were compared with each other without regard to MgCl 2 concentrations, in 26 instances a sample was identified as positive in 1 test but negative in 1 or more reactions run at the same or different MgCl 2 concentrations (i.e., false-negative test results). Of the 26 potentially false-negative results, in 17 cases the IC correctly classified a discrepant reaction as inhibited, whereas in the other 9 cases an IC result consistent with adequate amplification was observed but without IBDV-specific RT/PCR products. In 5 of the 9 disparate cases identifying a sample as positive, only trace amounts of IBDV RT/PCR-specific product was present, and the 4 remaining reactions contained good amounts of IBDV-specific product.
Discussion
The PCR and RT/PCR have been shown to be useful for the detection of minute quantities of nucleic acid target molecules. They, too, are complex reactions, which can be adversely affected by a number of different factors, including a variety of defined and undefined inhibitors that are found in sample materials, 4, 15, 19 as well as reagents used to prepare nucleic acid test samples, such as phenol, precipitation salts, guanidine, proteases, and SDS, which can inhibit the action of the polymerases used in the reactions. 1 Other contaminants, such as RNases and DNases, can interfere with test results by causing the degradation of the nucleic acids in a test sample. Assay failure may also occur as a result of any one of a number of technical errors that are possible during test preparation. An additional consideration when working with dsRNA, which composes the viral genome of IBDV, is that it must be denatured sufficiently so the test primers can compete with the reannealing of complementary genomic strands.
A number of PCR and RT/PCR test internal standards have been described. 23 These range in scope from ''generic'' controls based on the coamplification of ubiquitous or ''housekeeping'' genes (e.g., ␤-globin, 2 ) by the addition of a second primer set to a test reaction, to the construction of assay-specific standards containing priming sites in common with the wild-type target. Ubiquitous gene internal controls, although useful for assessing sample integrity and enzyme function, do not provide information on the performance of target primers. A variety of methods have been employed to produce internal standards that are specific for a particular test. One of the more common strategies involves the insertion of, or removal of, a fragment of sequence located between the priming sites of a cloned wild-type target DNA. These internal control reagents are coamplified with the same primer set as the targeted genomic material and are readily differentiated by size by standard electrophoresis methods. A variation of the previous method, and representative of the approach utilized for the IC in this study, involves the ligation of oligonucleotide linkers containing the target priming sites to a related or unrelated DNA fragment.
A number of factors are to be considered in the design of an IC. The amplification efficiency between 2 templates can vary because of differences in size, G-C content, and secondary structure. However, it is generally agreed that the most important factor determining overall amplification is related to the specific primers used. 5, 14 Considering these factors, the IBD IC was designed to have priming sites identical to, and be larger in size than, the IBDV target template. Because the sequence of the control was required to be free of the restriction sites used in our RFLP analysis, the use of a modified (deletion/insertion) IBD genome segment was not practical. As well, because the assay used in this study is qualitative, rather than quantitative, small differences in template amplification efficiency between the IC and IBD target because of differences in secondary structure and nucleic acid content are of minor importance.
Ideally, an IC for a RT/PCR assay requires the preparation of cRNA so that the performance of the RT reaction can be assessed. The use of plasmid constructs or cDNA reagents, used to monitor PCR test reactions, are not applicable because they do not address the performance of the RT reaction. The use of a cRNA agent does not necessarily provide information on the integrity of the sample material being tested, which, for instance, can be destroyed by contamination with RNase or by inappropriate handling. Because most RT/ PCR cRNA ICs are produced by in vitro transcription reactions, the DNA templates used for transcription must be removed; if not, PCR amplification of DNA templates carried over in the cRNA reagent could materially contribute to the IC product report in a RT/ PCR test. During the preparation of the IC in this study, this was found to be problematic. After several attempts to purify ssRNA IC transcripts that did not test positive for DNA templates, it was speculated that residual template adhering to the walls of the transcription reaction tube (1.5-ml siliconized Eppendorf) or condensate produced during the RQI-DNase incubation step was responsible for the carryover problem. To solve this problem, after the initial DNase digestion, the transcription reaction products were carefully transferred by pipette to a new siliconized Eppendorf tube and subjected to a second round of digestion with DNase. Though a small amount of PCR product was produced in the 10 Ϫ2 dilution of the IBDV cRNA transcript proofing reaction, no product was observed in additional tests completed for working dilutions (0.5 l of 10 Ϫ6 dilution/test) used in the IBDV RT/PCR test.
Adaptation of RT/PCR internal standards as competitors is common in quantitative-competitive RT/ PCR (QC-RT/PCR) assays. A quantitative-competitive PCR test (QC-PCR) has been described for IBDV in which a deletion mutant IBDV cDNA competitor is added at 10 ϫ serial dilutions to wild-type cDNA, produced in the RT reaction. 20 It is likely that the IC developed for this IBDV test, or a dsRNA reagent prepared by annealing complementary transcripts, could be used as an RNA competitor in a QC-RT/PCR assay. The use of an RNA-based competitor may have ad-vantages over the QC-PCR assay cDNA reagent by being able to more closely control for differences in the efficiency between individual RT reactions, which are reported to be quite variable. 22 The IC reagent has been a useful addition to the IBDV assay. RFLP analysis can be done only on samples for which sufficient RT/PCR product to digest has been obtained. The IC not only allows identification of reactions that have been totally inhibited (ϳ7.7% of tests) but, by assessing the amplification of the IC reagent, estimation of how well a test reaction performed is possible. Samples that inhibit tests or amplify poorly can be diluted, concentrated, reextracted, or run at different MgCl 2 concentrations to attempt to obtain a valid test result or sufficient product for RFLP analysis. Prior to use of the IC, this was a random process at best and, in the case of inhibited reactions, was overlooked.
Because the IC competes for the same primers, enzymes, and reaction substrates as target nucleic acids in the RT and PCR, it is possible for the IC to outcompete the target template for amplification. For this reason, the IC reagent should be added to a reaction mix only in the quantity needed for reliable amplification and detection of its PCR or RT/PCR product. In this laboratory, as mentioned in the results section, instances have been observed where amplification of the IC may have prevented amplification of IBDV target RNA, resulting in false-negative test results (3.4%, 9/268). In the majority of these cases, only a trace amount of IBDV-specific RT/PCR product was obtained. It is quite possible that the amplification success, or failure, observed for these test pairs is due more to test variation caused by the presence of inhibitors, poor sample quality, or marginal target density than to being out-competed by the IC.
In conclusion, the IC has helped improve the RT/ PCR-RFLP assay by identifying inhibited test reactions conducted on RNA extracts from frozen fresh bursal samples. As well, because of its ability to indicate the performance of individual tests (based on the IC RT/PCR product yield), it makes it possible to choose the most effective route for obtaining sufficient amounts of IBDV cDNA for RFLP determination. A single small-scale transcription reaction produced ssRNA transcripts sufficient to run millions of IBDV RT/PCR tests. The ssRNA reagent stock solution diluted to 10 Ϫ6 (320 femtograms/l) with depcH 2 O and stored at Ϫ20 C has shown no change in quality through storage times of greater than 18 months (data not shown). It is also possible this reagent could be adapted for use as an internal standard in a QC-RT/ PCR test.
